Parker Institute for Cancer Immunotherapy
For decades, entrenched infrastructure barriers have slowed progress in the fight against cancer and the development of potent immunotherapies. The Parker Institute for Cancer Immunotherapy breaks down these barriers. The result is groundbreaking new research and an intellectual property model that builds collaboration between researchers, nonprofits and industry all working together to get treatments to patients faster.www.parkerici.org
5
MENTIONS
3
EPISODES
3
PODCASTS
Search complete. 5 mentions across 3 episodes found for "Parker Institute for Cancer Immunotherapy".
Oct 1, 2026
PatrickHOST
Like-
TomHOST
I mean, his history with the Parker Institute, we could get into that
PatrickHOST
Institute, and like-
TomHOST
Yeah
Dylan DreyerHOST
We are so happy to have her back this morning to give us an exciting update on the progress.
Dylan DreyerHOST
Kristen is joined by cancer researcher Karen Knudsen, the CEO of the Parker Institute and the former CEO of the American Cancer Society.
Dylan DreyerHOST
Good morning to both of you.
Dylan DreyerHOST
Thank you for being here.
Dylan DreyerHOST
Tell us where it stands now and what you're doing.
Kristen DahlgrenGUEST
Yeah.
Kristen DahlgrenGUEST
So I've merged with the Parker Institute, which is really exciting.
Kristen DahlgrenGUEST
Look, I was at a meeting with the head of the National Cancer Institute earlier this week, and they were framing this as a generational opportunity in cancer research.
Steven FinkbeinerGUEST
That's where I did my clinical training ever since the institutes were formed.
Steven FinkbeinerGUEST
But we've really formed partnerships all throughout the Bay Area in this ecosystem, including with Stanford, UC Berkeley, the Biohub, the Parker Institute for Cancer Immunotherapy, and If you don't know anything about Gladstone, we are mission driven.
Steven FinkbeinerGUEST
And one of the things that we want to do and that I'm determined to do before my tombstone is written is really have an impact for patients.
Steven FinkbeinerGUEST
And so part of that is really trying to think very carefully about moving the things out of the laboratory to the clinic to be able to help people.